Global Health · NSE: MEDANTA · BSE: 543654
Q4 FY23 results · Jan–Mar 2023
Global Health reported revenue from operations of ₹703.42 crore and net profit of ₹101.07 crore for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 703.42 | — | — | 694.32 | +1.3% |
| Other income | 28.41 | — | — | 11.90 | +138.6% |
| Total income | 731.83 | — | — | 706.23 | +3.6% |
| Profit before tax | 133.08 | — | — | 112.45 | +18.3% |
| Net profit for the period | 101.07 | — | — | 80.61 | +25.4% |
| EPS, basic (₹) | 3.77 | — | — | 3.08 | not comparable |
| Net margin (%) | 14.4 | — | 11.6 |
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 502.91 | — | — | 489.79 | +2.7% |
| Other income | 28.10 | — | — | 12.52 | +124.4% |
| Total income | 531.01 | — | — | 502.31 | +5.7% |
| Profit before tax | 104.19 | — | — | 79.89 | +30.4% |
| Net profit for the period | 80.96 | — | — | 58.77 | +37.7% |
| EPS, basic (₹) | 3.02 | — | — | 2.25 | not comparable |
| Net margin (%) | 16.1 | — | 12.0 |
Consolidated
- Filed with BSE
- 27 May 2023, 19:50 IST
- Board meeting
- 27 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 27 May 2023, 19:50 IST
- Board meeting
- 27 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE